1. 2009
  2. Presence of a multidrug-resistance mutation in an HIV-2 variant infecting a treatment-naive individual in Caio, Guinea Bissau. / Jallow, S; Vincent, T; Leligdowicz, A; de Silva, T; Van Tienen, C; Alabi, A; Sarge-Njie, R; Aaby, P; Corrah, T; Whittle, H; Jaye, A; Vanham, G; Rowland-Jones, S; Janssens, W.

    In: Clinical Infectious Diseases, Vol. 48, No. 12, 2009, p. 1790-1793.

    Research output: Contribution to journalA1: Web of Science-article

  3. Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in The Gambia and emergence of drug-resistant variants. / Jallow, S; Alabi, A; Sarge-Njie, R; Peterson, K; Whittle, H; Corrah, T; Jaye, A; Cotten, M; Vanham, G; McConkey, SJ; Rowland-Jones, S; Janssens, W.

    In: Journal of Clinical Microbiology, Vol. 47, No. 7, 2009, p. 2200-2208.

    Research output: Contribution to journalA1: Web of Science-article

  4. 2008
  5. Optimization of the oligonucleotide ligation assay, a rapid and inexpensive test for detection of HIV-1 drug resistance mutations, for non-north American variants. / Beck, IA; Crowell, C; Kittoe, R; Bredell, H; Machaba, M; Willamson, C; Janssens, Wouter; Jallow, Sabelle; van der Groen, Guido; Shao, Y; Jacob, M; Samuel, NM; de Rivera, IL; Ngo-Giang-Huong, N; Cassol, S; Alemnji, G; Frenkel, LM.

    In: Journal of Acquired Immune Deficiency Syndromes, Vol. 48, No. 4, 2008, p. 418-427.

    Research output: Contribution to journalA1: Web of Science-article

  6. A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa [opinion]. / Gottlieb, GS; Eholié, SP; Nkengasong, JN; Jallow, Sabelle; Rowland-Jones, S; Whittle, H; Sow, PS.

    In: AIDS, Vol. 22, No. 16, 2008, p. 2069-2072.

    Research output: Contribution to journalA1: Web of Science-article

  7. Development and application of assays for monitoring drug resistance in HIV-2 infected patients on antiretroviral therapy. / Jallow, Sabelle.

    Antwerpen : Universiteit Antwerpen, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, 2008. 175 p.

    Research output: ThesisDoctoral dissertation - Doctoral dissertation

  8. 2007
  9. Development and evaluation of an oligonucleotide ligation assay for detection of drug resistance-associated mutations in the human immunodeficiency virus type 2 pol gene. / Jallow, S; Kaye, S; Schutten, M; Brandin, E; Albert, J; McConkey, SJ; Corrah, T; Whittle, H; Vanham, G; Rowland-Jones, S; Janssens, W.

    In: Journal of Clinical Microbiology, Vol. 45, No. 5, 2007, p. 1565-1571.

    Research output: Contribution to journalA1: Web of Science-article

  10. 2006
  11. Virological and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia [research letter]. / Jallow, S; Kaye, S; Alabi, A; Aveika, A; Sarge-Njie, R; Sabally, S; Corrah, T; Whittle, H; Vanham, G; Rowland-Jones, S; Janssens, W; McConkey, SJ.

    In: AIDS, Vol. 20, No. 10, 2006, p. 1455-1458.

    Research output: Contribution to journalA1: Web of Science-article

ID: 9238